Whole Exome Sequencing Market Players:
- Illumina, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio-Rad Laboratories Inc.
- Ambry Genetics
- Eurofins Discovery
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies Inc.
- BGI Group
- Macrogen Inc.
- Azenta US Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of whole exome sequencing is estimated at USD 3.12 billion.
The global whole exome sequencing market size was more than USD 2.66 billion in 2025 and is anticipated to witness a CAGR of more than 19.4%, crossing USD 15.66 billion revenue by 2035.
North America whole exome sequencing market will dominate more than 50.2% share by 2035, attributed to the rising prevalence of hereditary and chronic diseases and growing demand for targeted precision medicine.
Key players in the market include Illumina, Inc., Bio-Rad Laboratories Inc., Ambry Genetics, Eurofins Discovery, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., BGI Group, Macrogen Inc., Azenta US Inc.
